Shelly S Lo

Summary

Affiliation: Loyola University Medical Center
Country: USA

Publications

  1. ncbi Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
    Shelly S Lo
    Loyola University Medical Center, Cardinal Bernardin Cancer Center, 2160 S First Ave, Maywood, IL 60153, USA
    J Clin Oncol 28:1671-6. 2010
  2. ncbi A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas
    Shelly S Lo
    Loyola University Stritch School of Medicine, Maywood, Ill, USA
    Oncology 78:125-9. 2010

Detail Information

Publications2

  1. ncbi Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
    Shelly S Lo
    Loyola University Medical Center, Cardinal Bernardin Cancer Center, 2160 S First Ave, Maywood, IL 60153, USA
    J Clin Oncol 28:1671-6. 2010
    ..This multicenter study was designed to prospectively examine whether RS affects physician and patient adjuvant treatment selection and satisfaction...
  2. ncbi A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas
    Shelly S Lo
    Loyola University Stritch School of Medicine, Maywood, Ill, USA
    Oncology 78:125-9. 2010
    ..This multi-institutional phase II trial evaluates the combination of docetaxel and capecitabine as first- or second-line treatment in patients with advanced gastric and GE adenocarcinomas...